Groundbreaking
way of fighting
bacterial infections.
Silent Pandemic
Through a critical situation worldwide
During 2019 antibiotic-resistant infections play an important role killing over 5 million people worldwide. That’s nearly the double amount of people comparable to the populations of some major cities:
- Number of people per city
Los Angeles USA: 3.8 M
Toronto, Canada: 2.7 M
Paris, France: 2.1 M
Buenos Aires, Argentina: 3 M
Nairobi, Kenia: 4.9 M
Kalkuta, India: 4.4 M
Los Angeles USA: 3.8 M
Toronto, Canadá: 2.7 M
Paris, Francia: 2.1 M
Buenos Aires, Argentina: 3 M
Nairobi, Kenia: 4.9 M
Calcuta, India: 4.4 M
What could be expected by 2050
in health care costs
losses in production
in hospitalization
Increases of chemical/drug concentration in water.
We create specific, safe and sustainable alternatives combining microbiological, genomic and bioinformatic tools:
Bacteriophages are specific, safe and an ecologically friendly alternatives to traditional antibiotic treatments against infectious bacteria. On the other hand, phages have a wide scope of applications for human and animal health as well as for the environment and food preservation.
Bacteriophages
Bacteriophages are naturally occurring viruses that effectively kill specific bacteria hosts only. These specific viruses are considered safe for every other living organism including mammalians and plants.
We design solutions to improve animal and human health.
animal health
In Alytix, we are developing sustainable products around the clock base in not only threats but necessities of the poultry, pork and cattle sector to prevent and treat bacterial infections.
R&D
TEST
PRODUCT
FIELD TEST AND REGISTRATION
LAUNCH
INFECTIOUS DIARRHEA IN CALVES
E. coli / Salmonella spp.
BOVINE MASTITIS
S. aureus
DIARRHEA IN PIGS
E. coli
SALMONELLA IN POULTRY
Salmonella spp.
R&D
PRUEBAS DE
PRODUCTO
PRUEBA DE CAMPO Y REGISTRO
LANZAMIENTO
DIARREA INFECCIOSA EN TERNEROS
E. coli / Salmonella spp.
MASTITIS BOVINA
S. aureus
DIARREA EN CERDOS
E. coli
SALMONELLA EN AVES
Salmonella spp.
Impact on Sustainable Development Goals (SDGs)
TEAM
More than 10 years of experience on working with pathogenic bacteria and bacteriophages, collaborating with companies and research groups.
PARTNER
MARCELO SALAME
CEO & CO-FOUNDER
EXEQUIEL DUNAND
CSO & CO-FOUNDER
ENZO F. ZAMBONI
PRESIDENT & CO-FOUNDER
PARTNER
Contact us
- +54 (342) 4511546/7 Int. 1505
- info@alytixbiotech.com
- Parque Tecnológico Litoral Centro. Ruta Nacional N° 168, Km 0, S3000 Santa Fe.
